Vaishali Pharma Q4 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
8.64
-0.04 (-0.46%)
-0.04 (-0.46%)Volume33.91 K
Updated: Thu 17 Sep, 2026 | 10:09:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹26.93 Cr.(-16.49%)
- Operating Profit₹-0.36 Cr.(-94.13%)
- Profit After Tax₹0.27 Cr.(NA%)
- Operating Margin-1.34%(-92.97%)
Note: Comparison is on YoY basis
Quarterly - Vaishali Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 27.29 | 23.22 | 17.53% | 39.32 | -28.95% |
| Depreciation/ Amortization | 0.16 | 0.13 | 25.41% | 0.14 | 29.29% |
| Operating Income | -0.36 | 1.43 | 0.00% | -6.92 | -94.13% |
| Net Income | 0.27 | 1.32 | -79.79% | -4.68 | 0.00% |
| Other Operating Expenses Total | 1.90 | 1.43 | 32.38% | 6.23 | -72.52% |
| Net Income Before Taxes | 0.18 | 1.83 | -90.21% | -6.42 | 0.00% |
| Total Revenue | 26.93 | 24.65 | 9.23% | 32.40 | -16.49% |
| Selling/ General/ Admin Expenses Total | 0.78 | 0.72 | 7.41% | 0.63 | 4.95% |
| Diluted Normalized EPS | 0.02 | 0.10 | -80.98% | -0.44 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.